Follow-The-Filings

Security · featured owners

BDTX Black Diamond Therapeutics I

Health Care COM Equity among managers we track

BDTX (Black Diamond Therapeutics I) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 14 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 7.01,8.01,9.01
8-K 2.02,9.01
10-Q
DEFA14A
8-K 2.02,9.01
10-K
8-K 2.02,7.01,8.01,9.01
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 8 rows shown

Filed Form Detail Links
4 Period Jun 26, 2026 · 6 forms
4 Period Jun 19, 2026 · 2 forms
4 Period Mar 20, 2026 · 2 forms
4 Period Jan 21, 2026 · 5 forms
4 Period Dec 12, 2025 · 2 forms
4 Period Sep 19, 2025 · 2 forms
4 Period Jun 20, 2025 · 2 forms
4 Period Jun 12, 2025 · 4 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$82.44M -$69.68M $22.37M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $134.03M $101.18M $132.44M
Total non-current assets * $24.53M $21.46M $10.57M
Total assets $158.57M $122.64M $143.01M
Total current liabilities $19.65M $20.57M $15.73M
Total non-current liabilities * $22.18M $18.78M $15.07M
Total equity $116.74M $83.28M $112.21M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$66.72M -$62.3M $29.61M
Cash from investing $16.35M $16.97M -$44.9M
Cash from financing $71.93M $25.55M -$0.146M
Net change in cash $21.56M -$19.79M -$15.44M

ownership over time

filing count by report period · click a bar for that quarter’s holders